Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate mutase family member 4 (PGAM4) is a protein-coding gene located on the X chromosome that encodes a member of the phosphoglycerate mutase enzyme family, which catalyzes a key step in glycolysis by transferring a phosphate group from 3-phosphoglycerate to 2-phosphoglycerate[1][2][4][6]. This gene appears to have arisen from retrotransposition and is intronless, but is believed to be expressed and protein-coding[1][5]. PGAM4 is X-linked and may play a fundamental role in human male reproduction, potentially escaping meiotic sex chromosome inactivation[4]. PGAM4 is not generally recognized as a major therapeutic target or as having interacting drugs or established safety concerns; its clinical relevance appears secondary and mainly research-focused[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate mutase family member 4 (PGAM4).